Mycronic AB (publ)
MICLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $7,057,000 | $5,706,000 | $5,119,000 | $4,635,000 |
| % Growth | 23.7% | 11.5% | 10.4% | – |
| Cost of Goods Sold | $3,338,000 | $2,850,000 | $2,831,000 | $2,351,000 |
| Gross Profit | $3,719,000 | $2,856,000 | $2,288,000 | $2,284,000 |
| % Margin | 52.7% | 50.1% | 44.7% | 49.3% |
| R&D Expenses | $747,000 | $653,000 | $638,000 | $548,000 |
| G&A Expenses | $73,000 | $338,000 | $32,000 | $18,000 |
| SG&A Expenses | $338,000 | $996,000 | $286,000 | $228,000 |
| Sales & Mktg Exp. | $265,000 | $658,000 | $254,000 | $210,000 |
| Other Operating Expenses | $621,000 | $0 | $469,000 | $459,000 |
| Operating Expenses | $1,706,000 | $1,649,000 | $1,393,000 | $1,235,000 |
| Operating Income | $2,013,000 | $1,207,000 | $894,000 | $997,000 |
| % Margin | 28.5% | 21.2% | 17.5% | 21.5% |
| Other Income/Exp. Net | $71,000 | $55,000 | -$3,000 | $49,000 |
| Pre-Tax Income | $2,084,000 | $1,262,000 | $891,000 | $1,046,000 |
| Tax Expense | $396,000 | $266,000 | $154,000 | $219,000 |
| Net Income | $1,683,000 | $998,000 | $741,000 | $828,000 |
| % Margin | 23.8% | 17.5% | 14.5% | 17.9% |
| EPS | 8.63 | 5.11 | 3.8 | 4.24 |
| % Growth | 68.9% | 34.5% | -10.4% | – |
| EPS Diluted | 8.62 | 5.11 | 3.8 | 4.24 |
| Weighted Avg Shares Out | 97,590 | 97,652 | 97,597 | 97,649 |
| Weighted Avg Shares Out Dil | 97,590 | 97,636 | 97,610 | 97,709 |
| Supplemental Information | – | – | – | – |
| Interest Income | $78,000 | $40,000 | $9,000 | $11,000 |
| Interest Expense | $15,000 | $13,000 | $13,000 | $14,000 |
| Depreciation & Amortization | $266,000 | $137,000 | $209,000 | $100,000 |
| EBITDA | $2,365,000 | $1,388,000 | $1,112,000 | $1,152,000 |
| % Margin | 33.5% | 24.3% | 21.7% | 24.9% |